Completion of Public Tender Offer for Nichii Gakkan Co., Ltd. by LYFE Capital
Public Tender Offer Completed
On September 17, 2025, LYFE Capital announced the successful completion of the public tender offer for Nichii Gakkan Co., Ltd., a prominent healthcare group in Japan listed on the Tokyo Stock Exchange (TSE: 3341). This tender offer was conducted in collaboration with AP86 Corporation, a special purpose company backed by LYFE Capital and Advantage Partners (AP), which manages several funds. The successful offer includes Nichii Gakkan's prescription pharmacy operations, pharmaceutical manufacturing and sales, along with medical staffing and referral services.
LYFE Capital is uniquely positioned in the healthcare sector, leveraging extensive knowledge and networks, which when combined with AP's remarkable management improvement expertise developed over several decades, will substantially accelerate the growth of Nichii Gakkan. This strategic partnership aims to contribute significantly to the realization of the group's vision: "Facing the 'life' of every person."
About Nichii Gakkan Co., Ltd.
Founded with a mission to contribute to the health and well-being of society, Nichii Gakkan has diversified its services to become a cornerstone of Japan's healthcare system. Headquartered in Minato Ward, Tokyo, the company operates within a range of sectors including:
- - Prescription Pharmacy Services
- - Pharmaceutical Manufacturing and Sales
- - Medical Staffing and Referral Services
About LYFE Capital
Established in 2015, LYFE Capital focuses on investments in the global healthcare arena. With a presence in five locations across Asia and North America - including Menlo Park, Seoul, Singapore, Shanghai, and Tokyo - the company specializes in transforming healthcare ecosystems by supporting the growth of key companies within a diversified array of sectors, such as pharmaceuticals, medical devices, diagnostics, and healthcare services.
LYFE Capital prides itself on its skilled team with deep industry knowledge and an expansive global network, allowing them to make investments aimed at achieving sustainable revenue growth in mature markets. Currently, LYFE Capital manages over $2 billion in assets.
Future Directions
This partnership signifies a significant step forward for Nichii Gakkan. With the guidance of LYFE Capital and AP's expertise, the company is poised to enhance its operations and expand its influence in the healthcare sector. The organizations involved are committed to finding innovative ways to support better healthcare outcomes for individuals across Japan.
For further details, refer to the official announcement regarding the results of the public tender offer for Nichii Gakkan’s stocks, the changes in its parent company, major shareholders, and controller (excluding the parent company).
For more information on LYFE Capital, please visit www.lyfecapital.com.
Topics Business Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.